12:51 PM EST, 02/18/2025 (MT Newswires) -- AbCellera Biologics ( ABCL ) changed the title of Veronique Lecault to chief technology officer from chief operating officer, effective immediately.

Lecault's roles and responsibilities as COO will transfer to her position as chief technology officer, and the COO position will be dissolved, the company said Tuesday in a regulatory filing.

Price: 3.48, Change: +0.21, Percent Change: +6.42